Screener
10x Genomics, Inc. TXG Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s enterprise value?
- 10x Genomics, Inc. (TXG) reported enterprise value of $4.44B in Q2 2026.
- How has 10x Genomics, Inc.'s enterprise value changed year-over-year?
- 10x Genomics, Inc.'s enterprise value increased by 331.5% year-over-year, from $1.03B to $4.44B.
- What is the long-term trend for 10x Genomics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s enterprise value has grown at a -35.7% compound annual growth rate (CAGR), from $15.19B to $1.67B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about 10x Genomics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude